DEXTRA PARTNERS
DEXTRA PARTNERS is a Series C+ and buyout fund in the US investing in private-equity.
- Stages
- Series C+, buyout
- Sectors
- private-equity
- Invests in
- US-wide
- Round role
- Follows on
Check size not disclosed
Thesis
Dextra Partners is a private equity firm focused on the middle market, headquartered in New York City. Their strategy involves identifying and partnering with top-tier middle market sponsors, often from their inception or early fund stages, providing flexible capital solutions and institutional guidance. Dextra's investment approach includes primary fund commitments, secondaries, private debt, structured capital, equity co-investments, and GP seeding/staking. They seek to generate alpha-driven returns through a holistic, partnership-oriented business model. As of December 31, 2025, Dextra managed approximately $5.2 billion in regulatory assets under management (AUM). In August 2025, Dextra Partners announced the closing of its seventh co-investment fund, Dextra Co-investment Fund VII, at its hard cap of $825 million. Earlier, in January 2023, the firm announced its formation with $2.5 billion of investable capital from strategic partners. The firm operates as an independent, employee-owned entity with a focus on integrity, partnership, excellence, humility, and perspective.
Common questions
Does DEXTRA PARTNERS invest at the Series C+ stage?
Yes. DEXTRA PARTNERS lists Series C+ and buyout among the stages it invests in.
Where does DEXTRA PARTNERS invest?
DEXTRA PARTNERS invests in the US.